Review





Similar Products

phase 2 development • rexulti  (Lundbeck)
86
Lundbeck phase 2 development • rexulti
Phase 2 Development • Rexulti, supplied by Lundbeck, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rexulti/2+development+phase+rexulti+%E2%80%A2/sec_filing____1430306_slash_000138713119001745_slash_ex99___01-134-73-83
Average 86 stars, based on 1 article reviews
phase 2 development • rexulti - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
brexpiprazole (rexulti)  (Lundbeck)
90
Lundbeck brexpiprazole (rexulti)
Comparison of each neuropsychiatric symptom of patients with AD and general patients.
Brexpiprazole (Rexulti), supplied by Lundbeck, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rexulti/brexpiprazole+rexulti/pmc11547068-264-0-6
Average 90 stars, based on 1 article reviews
brexpiprazole (rexulti) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rexulti  (Lundbeck)
90
Lundbeck rexulti
New drugs for Alzheimer’s disease.
Rexulti, supplied by Lundbeck, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rexulti/rexulti/pmc11506318-20-6-15
Average 90 stars, based on 1 article reviews
rexulti - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rexulti® (brexpiprazole)  (Lundbeck)
90
Lundbeck rexulti® (brexpiprazole)
New drugs for Alzheimer’s disease.
Rexulti® (Brexpiprazole), supplied by Lundbeck, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rexulti/brexpiprazole+rexulti/pm38924384-182-9-9
Average 90 stars, based on 1 article reviews
rexulti® (brexpiprazole) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
brexpiprazole (rexulti)  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals brexpiprazole (rexulti)
New drugs for Alzheimer’s disease.
Brexpiprazole (Rexulti), supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rexulti/brexpiprazole++rexulti+/pm37114423-28-8-5
Average 90 stars, based on 1 article reviews
brexpiprazole (rexulti) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Comparison of each neuropsychiatric symptom of patients with AD and general patients.

Journal: International Journal of Molecular Sciences

Article Title: Future Therapeutic Strategies for Alzheimer’s Disease: Focus on Behavioral and Psychological Symptoms

doi: 10.3390/ijms252111338

Figure Lengend Snippet: Comparison of each neuropsychiatric symptom of patients with AD and general patients.

Article Snippet: Brexpiprazole (Rexulti), developed by Otsuka and Lundbeck, grained FDA approval in July 2015.

Techniques: Comparison, Concentration Assay, Activity Assay, Stripping Membranes

Candidates and mechanism of action under development for the treatment of AD-related neuropsychiatric symptoms.

Journal: International Journal of Molecular Sciences

Article Title: Future Therapeutic Strategies for Alzheimer’s Disease: Focus on Behavioral and Psychological Symptoms

doi: 10.3390/ijms252111338

Figure Lengend Snippet: Candidates and mechanism of action under development for the treatment of AD-related neuropsychiatric symptoms.

Article Snippet: Brexpiprazole (Rexulti), developed by Otsuka and Lundbeck, grained FDA approval in July 2015.

Techniques: Activation Assay

Comparison of mechanisms, symptoms, and therapeutic candidates of autism spectrum disorder and Alzheimer’s disease for social deficits.

Journal: International Journal of Molecular Sciences

Article Title: Future Therapeutic Strategies for Alzheimer’s Disease: Focus on Behavioral and Psychological Symptoms

doi: 10.3390/ijms252111338

Figure Lengend Snippet: Comparison of mechanisms, symptoms, and therapeutic candidates of autism spectrum disorder and Alzheimer’s disease for social deficits.

Article Snippet: Brexpiprazole (Rexulti), developed by Otsuka and Lundbeck, grained FDA approval in July 2015.

Techniques: Comparison, Isolation, Inhibition, Phospho-proteomics, Methylation, Migration, Transmission Assay

New drugs for Alzheimer’s disease.

Journal: Brain Sciences

Article Title: Advancements in Pharmacological Treatment of Alzheimer’s Disease: The Advent of Disease-Modifying Therapies (DMTs)

doi: 10.3390/brainsci14100990

Figure Lengend Snippet: New drugs for Alzheimer’s disease.

Article Snippet: Psychiatric Abnormalities Associated with AD , Rexulti , agitation , yes , high , Otsuka Pharmaceutical/Lundbeck , Full approval for marketing (2023).

Techniques: Bioprocessing